Oxford Pharmaceuticals Generic Drug Facility, Birmingham, Alabama

closed

In September 2015, US-based pharmaceutical start-up Oxford Pharmaceuticals broke ground on the construction of a generic drug manufacturing and distribution facility in Jefferson County, Birmingham, Alabama. Generic drug manufacturing and distribution facility Oxford Pharmaceuticals Jefferson County, Birmingham, Alabama September 2015 $29.4m August 2016 Robins and Morton, NOLA/Van Peursem Architects, Sian and Associates In September 2015, US-based pharmaceutical start-up Oxford Pharmaceuticals broke ground on the construction of a generic drug manufacturing and distribution facility in Jefferson County, Birmingham, Alabama. The facility was opened in August 2016. Built to comply with good manufacturing practices (GMP), the facility designs and produces various generic drugs for sale worldwide. Around 200 people are employed at the site. The ground-breaking ceremony for the facility was attended by officials such as Birmingham Governor Robert Bentley, Mayor William Bell, and Jefferson County Commissioner David Carrington. The state, city and county supported the project through a number of incentives. The project has created a range of jobs in Birmingham and contributed to its industrial and economic development. The plant is constructed on a 23.3-acre site in Jefferson Metropolitan Park at Lakeshore, 301 Leaf Lake Drive in Birmingham. The site was acquired from Jefferson County for $618,000. The county is estimated to gain around $1.35m in tax revenue from the project, including $97,490 in general tax revenue and $1.25m in educational tax revenue, over a ten-year period. Alabama’s largest metro area and resources such as the Innovation Depot and University of Alabama are the plant’s competitive advantages. The generic drug production facility was built with a $29.4m investment. Birmingham Business Alliance, the City of Birmingham, the Jefferson County Commission, the Jefferson County Economic Industrial Development Authority and the Alabama Department of Commerce co-operated with Oxford Pharmaceuticals by offering $4.9m in incentives, such as additional cash and infrastructural benefits. The city of Birmingham is providing financial incentives of up to $100,000 over ten years in annual payments of $10,000. In November 2014, Oxford Pharmaceuticals announced it would invest in its first plant in Birmingham. The facility spans around 120,000ft² and is built on a greenfield site in Metropolitan Park. Oxford Pharmaceuticals initially operated from Alabama’s Innovation Depot until operations at the plant started and staff had been recruited. The company moved to the new facility once its construction was complete. The company was aided by its use of the rent-free facility from Innovation Depot at the start-up stage, as well as government incentives. Local construction firm Robins and Morton was the general contractor for the project, while Huntsville-based practice NOLA/Van Peursem Architects provided design and architecture services. Local companySian and Associates offered engineering services for the project. Oxford Pharmaceuticals is a new venture based in Birmingham, Alabama. The company aims to produce, package and conduct research on generic drugs at the Alabama plant. It is determined to produce all varieties of generic drugs and sell them worldwide. Apart from the rent-free facility through Innovation Depot’s Soft Landing Designation, the start-up is also receiving life sciences and pharmaceutical consulting support from the University of Alabama in Birmingham. Get industry leading news, data and analysis delivered to your inbox Give your business an edge with our leading industry insights.

High